Page results
-
The autumn/winter edition of Charity Matters is out now.
-
Two clinicians with close links to UCLH and UCL have been appointed to be National Clinical Directors (NCD) by NHS England (NHSE) for 2024.
-
Two UCLH nurses who have dedicated their entire career to the NHS were invited to attend a VE Day celebration concert last Thursday.
-
The High Court has today ruled in favour of a judicial review claim which means children and young people may not be able to consent to hormone-blocking treatment in cases of gender dysphoria.
-
A groundbreaking e-learning course dedicated to improving care and understanding of Sickle Cell Disorder (SCD) has been officially launched, marking a significant milestone in the fight against health inequalities.
-
A cancer treatment that is currently available to only a limited number of UK patients is to be tested at UCLH in a countrywide clinical trial to see if it causes fewer long-term side effects than standard radiotherapy.
-
The Patient Advice and Liaison Service (PALS) provides impartial advice and assistance in answering questions and resolving concerns that patients, their relatives, friends and carers might have accessing the NHS services provided by UCLH.
-
Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.
-
A huge thank you and well done to everyone who ran the London Marathon last weekend to support UCLH.
-
The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.
File results
-
FOI/2022/0302 - Treatment with conditions for rheumatology/ dermatology
-
FOI/2022/0304 - Histopathology labs that run immunohistochemistry diagnostic testing
-
FOI/2022/0305 - Ethnic minority categories used for Gypsy, Roma, Traveller groups
-
FOI/2022/0306 - Policy and associates procedure using robotics
-
FOI/2022/0309 - In-patient deaths
-
FOI/2022/0314 - Use of herbicide containing glyphosate on hospital grounds
-
FOI/2022/0315 - Role of patient safety specialists within the Trust
-
FOI/2022/0317 - Inpatient mental health facilities
-
FOI/2022/0318 - HIMMS Electronic Medical Record Adoption Model (EMRAM) level achieved at Trust
-
FOI/2022/0325 - Number of patients on the public RTT pathway